Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kodiak Sciences (KOD) Other Non-Current Liabilities (2017 - 2026)

Kodiak Sciences filings provide 10 years of Other Non-Current Liabilities readings, the most recent being $100.0 million for Q1 2026.

  • Quarterly Other Non-Current Liabilities changed 0.0% to $100.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $100.0 million through Mar 2026, changed 0.0% year-over-year, with the annual reading at $100.0 million for FY2025, 0.0% changed from the prior year.
  • Other Non-Current Liabilities hit $100.0 million in Q1 2026 for Kodiak Sciences, roughly flat from $100.0 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $100.0 million in Q1 2023 and bottomed at $162000.0 in Q4 2022.
  • Average Other Non-Current Liabilities over 5 years is $87.5 million, with a median of $100.0 million recorded in 2023.
  • The largest annual shift saw Other Non-Current Liabilities crashed 99.82% in 2022 before it surged 61628.4% in 2023.
  • Kodiak Sciences' Other Non-Current Liabilities stood at $162000.0 in 2022, then surged by 61628.4% to $100.0 million in 2023, then changed by 0.0% to $100.0 million in 2024, then changed by 0.0% to $100.0 million in 2025, then changed by 0.0% to $100.0 million in 2026.
  • Per Business Quant, the three most recent readings for KOD's Other Non-Current Liabilities are $100.0 million (Q1 2026), $100.0 million (Q4 2025), and $100.0 million (Q3 2025).